For: | Balakumar P. Unleashing the pathological role of epithelial-to-mesenchymal transition in diabetic nephropathy: The intricate connection with multifaceted mechanism. World J Nephrol 2024; 13(2): 95410 [PMID: 38983761 DOI: 10.5527/wjn.v13.i2.95410] |
---|---|
URL: | https://www.wjgnet.com/2220-6124/full/v13/i2/95410.htm |
Number | Citing Articles |
1 |
Tingting Yuan, Hong Wang, Ting Kang, Weihua Wu, Santao Ou. Advancements in the non-invasive diagnosis of renal fibrosis. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1646412
|
2 |
Rucui Yu, Ruiying Wu, Tingting Chen, Yan Zhang, Xiangqing Chen. Yiqi Yangyin Tongluo Recipe Alleviates Diabetic Kidney Disease Through AGE-RAGE Signalling Axis. Diabetes, Metabolic Syndrome and Obesity 2025; : 2041 doi: 10.2147/DMSO.S523784
|
3 |
Yi Wei Chen, Shan He, Yu Wang, Lian Ying Hu, Qin Kai Chen, Si Yi Liu. Mitochondrial insights: key biomarkers and potential treatments for diabetic nephropathy and sarcopenia. Frontiers in Cell and Developmental Biology 2025; 13 doi: 10.3389/fcell.2025.1596204
|
4 |
Yan-ni Wang, Xin Wu, Qi-yan Shan, Qiao Yang, Xiao-yong Yu, Jian-hua Yang, Hua Miao, Gang Cao, Ying-yong Zhao. Acteoside-containing caffeic acid is bioactive functional group of antifibrotic effect by suppressing inflammation via inhibiting AHR nuclear translocation in chronic kidney disease. Acta Pharmacologica Sinica 2025; doi: 10.1038/s41401-025-01598-4
|
5 |
Bingxue Qi, Yang Chen, Siyang Chai, Xiaodan Lu, Li Kang. O‐linked β‐N‐acetylglucosamine (O‐GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy. Diabetic Medicine 2025; 42(2) doi: 10.1111/dme.15436
|